unc-13 homolog D
Zuletzt aktualisiert 8. Mai 2023
Erfüllt die redaktionelle Richtlinien
- HerunterladenHerunterladen
- Teilen
- Language
- Diskussion
- Ask Patient
- Audio-Version
- Zu bevorzugten Quellen bei Google hinzufügen
Der UNC13D gene provides instructions for making a protein that is involved in the process of cell destruction (cytolysis) and the regulation of the immune system.
Normal function
Der UNC13D gene provides instructions for making a protein that is involved in the process of cell destruction (cytolysis) and the regulation of the immune system.
The UNC13D protein is involved in the release of substances from cells (exocytosis). In particular, it is important for the exocytosis of structures called cytolytic granules from immune cells called T cells and NK cells. T cells and NK cells destroy other cells by secreting these cytolytic granules, which contain cell-killing proteins, onto the membranes of the target cells. The UNC13D protein helps transport these granules to the membrane of the target cell, allowing cytolytic proteins to enter the cell and trigger it to self-destruct.
This cytolytic mechanism also helps regulate the immune system by destroying unneeded T cells. Controlling the number of T cells prevents the overproduction of immune proteins called cytokines that lead to inflammation and which, in excess, cause tissue damage.
Conditions referring to this gene or chromosome
Other names
FHL3
HLH3
HPLH3
Munc13-4
UN13D_HUMAN
Related patient information and medicines

Patient information leaflet
Cholesteatom
Cholesteatoma is the name given to a collection of skin cells that form a pearly-white greasy-looking lump deep in the ear, usually at the top of the area behind the eardrum. A cholesteatoma is a non-cancerous abnormal growth of skin-like tissue in the middle ear. This condition is uncommon. Around 7-13 people per 100,000 of the population will be.

Patient information leaflet
Schwangerschaftsscreening-Tests
It can develop into a serio... It can be treated with antibiotics. Diabetes. If you have had a history of diabetes in a previous pregnancy ( gestational diabetes Diabetes and pregnancy ) then you will be tested for Diabetes by a blood test in future pregnancies. In addition, you may be offered a test for diabetes if you have risk factors for.

Patient information leaflet
BRCA-Gene
There are a few known gene changes (mutations) that can increase the risk of certain cancers, and tests available for some of them, including BRCA1 und BRCA2 gene mutations. Men with a BRCA1 or BRCA2 mutation have an increased risk of prostate... Breast cancer About 13 in 100 women will develop breast cancer sometime during their lives. Some.

Patient information leaflet
Verhütungsmethoden
For the example of injections, between 3 und 60 women out of every 1,000 using this method will fall pregnant. When no contraception is used, around 85 in 100 sexually active women become pregnant within one year. The effectiveness of some methods depends on how you use them. T... Between 3 and 60 women in every 1,000 using it will become.

Patient information leaflet
Down-Syndrom-Screening
As mentioned above, every woman has a chance of having a baby with Down's syndrome. A screening test ist offered to all women in the UK during early Schwangerschaft to look at the chance in this pregnancy of the baby being born with Down's syndrome. It is important to understand that the Down's syndrome screening test does not give a definite 'yes' or.

Patient information leaflet
Hodentorsion
When a testicle (testis) twists around in the scrotum, the condition is called testicular torsion. An emergency operation is usually needed to treat this condition. What is testicular torsion. If... Musculature and inner workings of the scrotum Musculature and inner workings of the scrotum How common is testicular torsion. Testicular torsion.
Weiterführende Lektüre und Referenzen
- unc-13 homolog D; MedlinePlus, National Library of Medicine.
- Cetica V, Pende D, Griffiths GM, Arico M. Molecular basis of familial hemophagocytic lymphohistiocytosis. Haematologica. 2010 Apr;95(4):538-41. doi: 10.3324/haematol.2009.019562. No abstract available.
- Filipovich AH. Hemophagocytic lymphohistiocytosis and related disorders. Curr Opin Allergy Clin Immunol. 2006 Dec;6(6):410-5. doi: 10.1097/01.all.0000246626.57118.d9.
- Horne A, Ramme KG, Rudd E, Zheng C, Wali Y, al-Lamki Z, Gurgey A, Yalman N, Nordenskjold M, Henter JI. Characterization of PRF1, STX11 and UNC13D genotype-phenotype correlations in familial hemophagocytic lymphohistiocytosis. Br J Haematol. 2008 Oct;143(1):75-83. doi: 10.1111/j.1365-2141.2008.07315.x. Epub 2008 Aug 15.
- Pivot-Pajot C, Varoqueaux F, de Saint Basile G, Bourgoin SG. Munc13-4 regulates granule secretion in human neutrophils. J Immunol. 2008 May 15;180(10):6786-97. doi: 10.4049/jimmunol.180.10.6786.
- Rudd E, Bryceson YT, Zheng C, Edner J, Wood SM, Ramme K, Gavhed S, Gurgey A, Hellebostad M, Bechensteen AG, Ljunggren HG, Fadeel B, Nordenskjold M, Henter JI. Spectrum, and clinical and functional implications of UNC13D mutations in familial haemophagocytic lymphohistiocytosis. J Med Genet. 2008 Mar;45(3):134-41. doi: 10.1136/jmg.2007.054288. Epub 2007 Nov 9.
- Santoro A, Cannella S, Trizzino A, Bruno G, De Fusco C, Notarangelo LD, Pende D, Griffiths GM, Arico M. Mutations affecting mRNA splicing are the most common molecular defect in patients with familial hemophagocytic lymphohistiocytosis type 3. Haematologica. 2008 Jul;93(7):1086-90. doi: 10.3324/haematol.12622. Epub 2008 May 19.
- Zhang K, Biroschak J, Glass DN, Thompson SD, Finkel T, Passo MH, Binstadt BA, Filipovich A, Grom AA. Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 polymorphisms. Arthritis Rheum. 2008 Sep;58(9):2892-6. doi: 10.1002/art.23734.
- Zur Stadt U, Beutel K, Kolberg S, Schneppenheim R, Kabisch H, Janka G, Hennies HC. Mutation spectrum in children with primary hemophagocytic lymphohistiocytosis: molecular and functional analyses of PRF1, UNC13D, STX11, and RAB27A. Hum Mutat. 2006 Jan;27(1):62-8. doi: 10.1002/humu.20274.
Artikelverlauf
Artikel auch verfügbar in Englisch, Deutsch, Spanisch, Französisch, Italienisch, Portugiesisch, Hindi, Hebräisch, Arabisch, und Schwedisch.
8. Mai 2023 | Neueste Version
1 Jan 2011 | Ursprünglich veröffentlicht
Teilen Sie Ihre Gedanken oder Erfahrungen mit anderen in unserem Patientengemeinschaften.
Abonnieren Sie den Patienten-Newsletter
Ihre wöchentliche Dosis klarer, vertrauenswürdiger Gesundheitsberatung - geschrieben, um Ihnen zu helfen, sich informiert, selbstbewusst und in Kontrolle zu fühlen.
Durch das Abonnieren akzeptieren Sie unsere Datenschutzrichtlinie. Sie können sich jederzeit abmelden. Wir verkaufen Ihre Daten niemals.

